Cognetivity Sees Pilot Program Transition Into Commercial Agreement In UAE
A successful pilot program has lead to a commercial arrangement for Cognetivity Neurosciences (CSE: CGN). The firm this morning revealed
Read more
Healthcare
Well Health Claims Record Revenues In May, Provides No Hard Details
Well Health Technologies (TSX: WELL) this morning attempted to rally its base amidst its endless slow selloff in the markets.
Read more
Cognetivity To Deploy Cognitive Assessment Tool Across Largest Healthcare Network In UAE
Cognetivity Neurosciences (CSE: CGN) continued to take the Middle East by storm this morning. The firm has continued its pattern
Read more
After Causing Investors To Lose US$116 Million, SCWorx Agrees To US$1.2 Million Settlement
The Securities and Exchange Commission announced on Tuesday that it has filed securities fraud charges against SCWorx Corp. (Nasdaq: WORX) and
Read more
CloudMD’s “Strategic Plan” Starts With $41.4 Million In Revenue, $5.6 Million Net Loss For Q1 2022
In the wake of the consecutive resignations of its CEO and CFO, CloudMD Software & Services Inc. (TSXV: DOC) maintains
Read more
Well Health: Canaccord Slashes Price Target To $6
On May 11th, WELL Health Technologies Corp. (TSX: WELL) reported its first quarter financial results. The company reported revenues of
Read more
Cognetivity To Deploy Flagship Assessment Tool At Florida-Based Clinic
The rollout of Cognetivity Neurosciences’ (CSE: CGN) flagship product, the CognICA cognitive assessment tool, continues. The firm this morning announced
Read more
Well Health Looks To Raise $30 Million At $3.70 Per Share
Never wanting to put a good cash-producing opportunity to waste, Well Health (TSX: WELL) this morning announced it intends to
Read more
WELL Health Posts $126.5 Million In Revenue, $2.3 Million Net Loss In Q1 2022
WELL Health Technologies Corp. (TSX: WELL) reported today its financial performance for Q1 2022. The results highlighted a quarterly revenue
Read more
Eye Care Firm Bausch + Lomb Seeks To Raise $630 Million In NYSE, TSX IPOs
Bausch Health Companies (NYSE/TSX: BHC) subsidiary, eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) started trading its securities today.
Read more